ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,389, issued on April 21, was assigned to iOnctura SA (Geneva, Switzerland).
"PI3K-Delta inhibitor for use in treatment regimens" was invented by Catherine Pickering (Geneva), Lars Van Der Veen (Geneva), Michael Lahn (Geneva), Rebeca Zorrilla (Geneva) and Zoe Johnson (Geneva).
According to the abstract* released by the U.S. Patent & Trademark Office: "A compound or a pharmaceutically acceptable salt thereof for use in a method of treatment of a disease or condition in which signalling through the PI3KDelta pathway is pathologically implicated in patients, for example cancer and inflammatory or autoimmune diseases. The compound is provided at a specified dose and has been found to...